Moderna, Pfizer blueprints revealed: Vaccine frontrunners bow to public pressure, abandon secrecy

Companies typically share these documents after their studies are complete. The disclosures while the trials are still underway, a rare move, are aimed at addressing growing suspicion among Americans that President Donald Trump’s drive to produce a vaccine before the election on Nov. 3 could result in a product that was unsafe.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3mFodvh
via IFTTT